ALEXANDRIA, Va., Feb. 5 -- United States Patent no. 12,215,112, issued on Feb. 4, was assigned to ESFAM BIOTECH PTY LTD (Melbourne, Australia).
"CD151 inhibitors" was invented by John Thomas Feutrill (Rosanna, Australia), Jean-Marc Garnier (Ocean Grove, Australia) and Albert George Frauman (Melbourne, Australia).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to compounds of formula (I) that have the ability to inhibit CD151."
The patent was filed on July 27, 2021, under Application No. 18/006,978.
*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.ht...